|
US20010006629A1
(en)
*
|
1993-10-25 |
2001-07-05 |
Richard J. Gregory |
Recombinant adenoviral vector and methods of use
|
|
US6210939B1
(en)
|
1993-10-25 |
2001-04-03 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US20060275261A1
(en)
*
|
1993-10-25 |
2006-12-07 |
Canji, Inc. |
Adenoviral vectors having a protein IX deletion
|
|
EP1637608B1
(en)
*
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US7001733B1
(en)
|
1998-05-12 |
2006-02-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement
|
|
US7060433B1
(en)
|
1999-11-12 |
2006-06-13 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening using diphtheria toxin constructs
|
|
DE19845434C1
(de)
*
|
1998-10-02 |
2000-03-16 |
Juergen Schrader |
Gewebebindende Peptide, ihre Identifizierung, Herstellung und Verwendung
|
|
JP5448283B2
(ja)
*
|
1998-11-19 |
2014-03-19 |
ジョージタウン・ユニバーシティ |
全身性ウイルス／リガンド遺伝子送達システムおよび遺伝子治療
|
|
DK2385124T3
(da)
|
1999-05-14 |
2013-11-18 |
Arbor Vita Corp |
Peptider, eller peptid-analoger, til modulering af bindingen af et PDZ protein og et PL protein
|
|
EP1223952B1
(en)
*
|
1999-10-07 |
2008-04-16 |
Carlos Estuardo Aguilar-Cordova |
Methods for treatment of solid tumors and metastasis by gene therapy
|
|
WO2001026643A1
(en)
*
|
1999-10-14 |
2001-04-19 |
The Wistar Institute |
Inhibition of tumorigenic properties of melanoma cells
|
|
AU2001234981A1
(en)
|
2000-02-09 |
2001-08-20 |
Genvec, Inc. |
Adenoviral capsid containing chimeric protein ix
|
|
WO2001066148A1
(en)
*
|
2000-03-08 |
2001-09-13 |
Neurosearch A/S |
A method of sensitising endothelial cells to prodrugs
|
|
CA2414272A1
(en)
*
|
2000-07-10 |
2002-01-17 |
Novartis Ag |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
US6506365B1
(en)
*
|
2000-09-25 |
2003-01-14 |
Baxter Aktiengesellschaft |
Fibrin/fibrinogen binding conjugate
|
|
CN1520303B
(zh)
*
|
2001-03-27 |
2013-04-24 |
纽约大学 |
利用基于α病毒且靶向高亲和性层粘连蛋白受体的载体进行肿瘤治疗
|
|
US20050043227A1
(en)
*
|
2001-04-24 |
2005-02-24 |
Veerle Compernolle |
Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension
|
|
JP2002335965A
(ja)
*
|
2001-05-14 |
2002-11-26 |
Japan Science & Technology Corp |
細胞特異的発現複製ベクター
|
|
EP1399023B1
(en)
*
|
2001-06-01 |
2008-04-30 |
Wyeth |
COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9;
|
|
WO2002103004A1
(en)
*
|
2001-06-15 |
2002-12-27 |
The Children's Hospital Of Philadelphia |
Surface modification for improving biocompatibility
|
|
KR101072867B1
(ko)
*
|
2001-10-31 |
2011-10-17 |
유니버시티 오브 노스 텍사스 헬스 사이언스 센터 |
뼈 형태발생 단백질(ｂｍｐ), ｂｍｐ 수용체 및 ｂｍｐ 결합 단백질 및 녹내장 진단 및 치료에서 그의 용도
|
|
US20030133912A1
(en)
*
|
2001-12-11 |
2003-07-17 |
Davidson Beverly L. |
Receptor-targeted adenoviral vectors
|
|
FR2842823A1
(fr)
*
|
2002-07-25 |
2004-01-30 |
Inst Nat Sante Rech Med |
Adenovirus modifies pour le ciblage des lymphocytes b
|
|
US7033333B1
(en)
*
|
2002-08-02 |
2006-04-25 |
Arthur Croft |
Self actuated cervical (neck) traction device
|
|
WO2004029581A2
(en)
*
|
2002-09-26 |
2004-04-08 |
The Children's Hospital Of Philadelphia |
Method of determining surface binding capacity
|
|
CN1327899C
(zh)
*
|
2003-05-10 |
2007-07-25 |
彭朝晖 |
腺病毒载体与p53基因的基因重组体的应用
|
|
US20070098702A1
(en)
*
|
2005-02-17 |
2007-05-03 |
University Of Maryland, Baltimore |
Recombinant protein polymer vectors for systemic gene delivery
|
|
WO2007050128A2
(en)
*
|
2005-05-31 |
2007-05-03 |
Vectorlogics, Inc. |
Shielded adenoviral vectors and methods of use
|
|
US20100150885A1
(en)
*
|
2005-06-01 |
2010-06-17 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
|
WO2007061141A1
(ja)
|
2005-11-24 |
2007-05-31 |
Genomidea, Inc. |
改変パラミクソウイルスおよびその作製方法
|
|
US7659999B2
(en)
*
|
2005-12-23 |
2010-02-09 |
Xerox Corporation |
UIdesign: N-up calculator user interface
|
|
EP1989326A4
(en)
|
2006-01-17 |
2009-09-30 |
Health Research Inc |
BIO-HETERODUPLEX TRACKING TEST
|
|
WO2008128251A1
(en)
*
|
2007-04-17 |
2008-10-23 |
The Children's Hospital Of Philadelphia |
Humanized viral vectors and methods of use thereof
|
|
JP5763525B2
(ja)
*
|
2008-05-07 |
2015-08-12 |
サーモディクス，インコーポレイティド |
粒子からの核酸複合体の送達
|
|
US20110159098A1
(en)
*
|
2009-12-30 |
2011-06-30 |
Surmodics, Inc. |
Stabilization and delivery of nucleic acid complexes
|
|
WO2011127340A2
(en)
*
|
2010-04-08 |
2011-10-13 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system that allows multiple applications
|
|
US8389804B2
(en)
|
2010-04-08 |
2013-03-05 |
University Of Florida Research Foundation, Inc. |
Viral based transient-expression vector system that allows multiple applications
|
|
US8901092B2
(en)
|
2010-12-29 |
2014-12-02 |
Surmodics, Inc. |
Functionalized polysaccharides for active agent delivery
|
|
RU2542385C2
(ru)
*
|
2012-08-31 |
2015-02-20 |
Общество с ограниченной ответственностью "НекстГен" |
Способ получения фармацевтической композиции для индукции развития кровеносных сосудов в тканях, фармацевтическая композиция, полученная этим способом, и способ лечения ишемии тканей и/или органов человека
|
|
US10947282B2
(en)
|
2015-01-19 |
2021-03-16 |
The Texas A & M University System |
Functionalized protein-based materials and their uses
|
|
RU2612497C2
(ru)
|
2015-05-26 |
2017-03-09 |
Общество с ограниченной ответственностью "НекстГен" |
Оптимизированная нуклеотидная последовательность и фармацевтическая композиция на ее основе с пролонгированной экспрессией трансгена vegf
|
|
WO2018213235A1
(en)
|
2017-05-16 |
2018-11-22 |
Life Technologies Corporation |
Methods for compression of molecular tagged nucleic acid sequence data
|
|
US20220340627A1
(en)
*
|
2019-09-20 |
2022-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Dach1 builds artery networks that protect against cardiac injury in adults
|